The publication aims to test an association between the number of disease-modifying therapy (DMT) dispensations per year and the number of hospitalizations for people with multiple sclerosis.
Citation
Al-Sakran L, Marrie RA, Blackburn D, et alAssociation between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study. BMJ Open 2019; 9: e 033599. doi: 10.1136/bmjopen-2019-033599